$44.52▼-1.30 (-2.84%)
Extended:$45.82+1.30 (+2.92%)· 10:23 PM ET
Chugai Pharmaceutical Co., Ltd. (CHGCF)
R&D to Revenue
14.91%
Fiscal year · Period ending:

CHGCF R&D to Revenue
Latest reported14.91%period ending
Latest reported14.91%period ending
CHGCF FY R&D/Revenue (0.00% → 14.91%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
CHGCF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.9131% | |
| 15.0984% | |
| 14.8253% | |
| 11.7751% | |
| 13.1308% | |
| 14.8169% | |
| 15.2631% | |
| 16.2008% | |
| 16.6266% | |
| 16.7813% | |
| 16.4023% | |
| 17.5206% | |
| 17.5318% | |
| 17.2246% | |
| 14.9541% | |
| 14.4139% | |
| 12.8955% | |
| 16.2799% | |
| 15.7314% | |
| 16.7456% | |
| 15.301% | |
| 16.3454% | |
| 0% |
Explore More
CHGCF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance